Our study demonstrated that the expression and methylation level of METTL3 has a tight relationship with ovarian cancer development and further identified that METTL3 stimulated the m6A modification of miR-1246 to promote miR-1246 expression, which subsequently downregulates the expression of CCNG2 (Fig. 9). The gene discussed is METTL3; the disease is ovarian carcinoma.